Oramed Pharmaceuticals Inc. - Sep 30, 2025 SCHEDULE 13G/A Report for Scilex Holding Co Common Stock, par value $0.0001 per share (SCLX)

Filing Manager: Oramed Pharmaceuticals Inc.
Reporting Manager: Oramed Pharmaceuticals Inc.
Security: Scilex Holding Co Common Stock, par value $0.0001 per share
Symbol: SCLX
Shares outstanding: 8.42M shares
Disclosed Ownership: 833K shares
Ownership: 9.9%
Form type: SCHEDULE 13G/A
Date filed: 11/14/2025, 04:30 PM
Date of event: Sep 30, 2025
Previous filing: Aug 14, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Oramed Pharmaceuticals Inc.	9.9%	833K	833K	0	/s/ Avraham Gabay	Avraham Gabay, Chief Financial Officer